Get the Stockscreener App
3.35
0.30%
-0.02
Pluri Inc stock is traded at $3.35, with a volume of 5,677.
It is down -0.30% in the last 24 hours and down -9.54% over the past month.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
See More
Previous Close:
$3.33
Open:
$3.27
24h Volume:
5,677
Relative Volume:
0.38
Market Cap:
$33.37M
Revenue:
$1.34M
Net Income/Loss:
$-27.11M
P/E Ratio:
-1.0289
EPS:
-3.2559
Net Cash Flow:
$-22.01M
1W Performance:
+6.07%
1M Performance:
-9.54%
6M Performance:
-28.60%
1Y Performance:
-25.06%
1-Day Range:
$3.27
$3.32
1-Week Range:
$3.01
$3.48
52-Week Range:
$2.82
$7.13
Pluri Inc Stock (PLUR) Company Profile
Name
Pluri Inc
Sector
Industry
Phone
972-74-710-7171
Address
MATAM ADVANCED TECHNOLOGY PARK, HAIFA
Compare PLUR vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLUR
Pluri Inc
|
3.32 | 33.47M | 1.34M | -27.11M | -22.01M | -3.2559 |
VRTX
Vertex Pharmaceuticals Inc
|
451.39 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
754.55 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
329.82 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
687.64 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.26 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Pluri Inc Stock (PLUR) Latest News
Pluri's chairman paid 30% above market in a new $2.5M buy - Stock Titan
Aug PostEarnings: How do insiders feel about Pluri IncIPO Watch & Expert Verified Movement Alerts - baoquankhu1.vn
If You Invested $1,000 in Pluri Inc (PLUR) - Stock Titan
PLUR PE Ratio & Valuation, Is PLUR Overvalued - Intellectia AI
S P Trends: Will Pluri Inc outperform during market rallies2026 Geopolitical Influence & High Conviction Trade Alerts - baoquankhu1.vn
Pluristem Secures Nasdaq Listing and Expands Intellectual Property in China () - aktiencheck.de
Plurilock Security Inc.: Plurilock Provides Corporate Update - FinanzNachrichten.de
Pluri Regains Nasdaq Compliance, Restoring Listing Stability - TipRanks
Panic Selling: Is Pluri Inc stock a value trapPortfolio Update Summary & High Conviction Trade Alerts - baoquankhu1.vn
Pluri regains Nasdaq compliance after meeting market value requirement By Investing.com - Investing.com UK
Pluri regains Nasdaq compliance after meeting market value requirement - Investing.com
Pluri regains Nasdaq listing compliance after MVLS threshold met - TradingView
Pluri (NASDAQ: PLUR) regains key Nasdaq listing standard compliance - Stock Titan
Options Flow: Does Pluri Inc have strong fundamentals2025 Trading Volume Trends & Fast Moving Stock Trade Plans - baoquankhu1.vn
Volume Report: What are Pluri Incs technical support levelsPortfolio Risk Report & Reliable Trade Execution Plans - baoquankhu1.vn
Insider Sell: Is Pluri Inc part of any major indexJuly 2025 Setups & Community Verified Swing Trade Signals - baoquankhu1.vn
MSN Money - MSN
Pluri Biotech Secures China Patent for Immune Cell Tech - Contract Pharma
Pluri (PLUR) Secures Key Patent in China for 3D Cell Expansion T - GuruFocus
Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent - The Manila Times
Pluri lands China patent for tech to mass-produce immune cells - Stock Titan
Pluri Inc. (NASDAQ:PLUR) Sees Large Increase in Short Interest - Defense World
Can Pluri Inc. (4DX) stock stage a strong rebound this quarterJuly 2025 Macro Moves & Weekly High Potential Stock Alerts - mfd.ru
Why analysts maintain buy rating on Pluri Inc. (4DX) stockTrade Risk Assessment & Risk Managed Investment Signals - mfd.ru
Pluri: Overview of Second Quarter Financial Results - Bitget
Pluri: Fiscal Q2 Earnings Snapshot - kare11.com
Pluri Inc. SEC 10-Q Report - TradingView
Pluri: Fiscal Second Quarter Earnings Overview - Bitget
Pluri showcases cell expansion platform as Resbiomed program advances - Proactive financial news
Dividend Watch: What is Pluri Inc.’s TAM (Total Addressable Market)Market Risk Analysis & Long-Term Safe Return Strategies - baoquankhu1.vn
Sentiment Recap: Is Pluri Inc stock a value trapDay Trade & Verified Technical Trade Signals - baoquankhu1.vn
Quarterly Risk: Can IDYA weather a recessionQuarterly Portfolio Review & Verified Entry Point Detection - baoquankhu1.vn
What are Pluri Inc.’s technical support levels2025 Valuation Update & Long Hold Capital Preservation Plans - mfd.ru
The New "Picasso" Strategy: Pluri Unlocks Hidden Asset Value Through Vertical Focus - citybiz
Aug Catalysts: How do insiders feel about Pluri IncWeekly Investment Summary & Technical Pattern Alert System - baoquankhu1.vn
Nasdaq Moves: Is Biglari Holdings Inc stock a falling knife or bargain buy - baoquankhu1.vn
Pluri Faces Nasdaq Noncompliance Notice, Evaluating Listing Options - TipRanks
Pluri Disclosed Failure to Satisfy a Continued Listing Rule or Standard - tradingview.com
Pluri (PLUR) Completes Initial Phase with Resbiomed Technologies - GuruFocus
Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials - The Manila Times
Inside the push to turn human placentas into collagen for new therapies - Stock Titan
Jobs Data: Can Pluri Inc maintain its current growth rateLayoff News & Weekly Market Pulse Alerts - baoquankhu1.vn
What is Pluri Incs TAM Total Addressable Market2025 Market Trends & Technical Pattern Based Signals - baoquankhu1.vn
Harel Insurance Investments & Financial Services Ltd. Purchases 103,430 Shares of Enlight Renewable Energy Ltd. $ENLT - Defense World
Pluri Inc. (NASDAQ:PLUR) Short Interest Update - Defense World
Heritage Media Corp. (OTCMKTS:OLVI) Sees Significant Growth in Short Interest - Defense World
A US$2.9m Market Cap Boost Pleasing ToPluri Insiders - Sahm
Published on: 2026-01-13 06:29:23 - ulpravda.ru
Consolidated Lithium Metals (CVE:CLM) Shares Up 30% – What’s Next? - Defense World
Real Time Chart Alerts Flash Bullish on Mahanagar Telephone Nigam LimitedHigh Beta Stocks & Free Significant Capital Appreciation - Bollywood Helpline
How sustainable is Pluri Inc. stock dividend payout2025 Market WrapUp & Free Weekly Watchlist of Top Performers - Улправда
Pluri Inc Stock (PLUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pluri Inc Stock (PLUR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Manieu Alexandre Weinstein | Director |
Apr 28 '25 |
Buy |
4.61 |
452,702 |
2,086,956 |
452,702 |
| Manieu Alexandre Weinstein | Director |
Apr 28 '25 |
Buy |
4.61 |
976,139 |
4,500,001 |
931,246 |
0.99%
3.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):